Back to IEQ Capital, LLC IEQ Capital, LLC

REGNREGN

Showing 8 of 27 quarters

Position history for IEQ Capital, LLCIEQ Capital, LLC's holdings in Regeneron Pharmaceuticals, Inc.

Yes. IEQ Capital holds 48,105 shares of REGN (Regeneron Pharmaceuticals), worth $30M, as of its Q2 2026 13F filing. It reduced the position by 30,197 shares (-38.6%) from Q1 2026. IEQ Capital has held REGN since Q1 2021, across 22 quarterly 13F filings. REGN is 0.1% of IEQ Capital's reported 13F portfolio.

Current Value

$30M

Current Shares

48,105

Total Value Change

+$24.4M

Total Shares Change

+42,771

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
48,105
-38.6%
$30M0.1%$622.81
0
2026-Q1
Increased
78,302
+14.1%
$60.5M0.3%$770.59
40
2025-Q4
Increased
68,637
+57.2%
$53M0.2%$768.90
50
2025-Q3
Increased
43,660
+1015.8%
$24.5M0.1%$559.40
46
2025-Q2
Decreased
3,913
-52.4%
$2.1M0.0%$521.53
0
2025-Q1
Increased
8,219
+114.2%
$5.2M0.0%$629.11
44
2024-Q4
Decreased
3,838
-28.1%
$2.7M0.0%$705.67
0
2024-Q3
Decreased
5,334
-3.6%
$5.6M0.1%$1,041.41
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used